Detalhe da pesquisa
1.
The GPR40 novel agonist SZZ15-11 improves non-alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet-induced obese mice.
Diabetes Obes Metab
; 26(6): 2257-2266, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497233
2.
Voglibose Regulates the Secretion of GLP-1 Accompanied by Amelioration of Ileal Inflammatory Damage and Endoplasmic Reticulum Stress in Diabetic KKAy Mice.
Int J Mol Sci
; 23(24)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555580
3.
New anti-diabetic drug Morus alba L. (Sangzhi) alkaloids (SZ-A) improves diabetic nephropathy through ameliorating inflammation and fibrosis in diabetic rats.
Front Med (Lausanne)
; 10: 1164242, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37359004